|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||-0.03|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Transgenomic, Inc. today reported that the European Patent Office has confirmed its intention to grant a patent covering multiplexed ICE COLD-PCR technology in the European Union .
Transgenomic, Inc. today announced that its stockholders have approved the merger with Precipio Diagnostics, LLC. Upon completion of the merger, the company expects t
Transgenomic, Inc. , today announced that its Board of Directors confirms its special meeting of stockholders will be held on June 5, 2017 at Troutman Sanders LLP’s offices located at 1001 Haxall Point, Richmond, Virginia 23219.